24/7 MN (NASDAQ: CDTX) CIDEARA THEREPEUTICS INC shares are moving up more than 14% in pre-market as they announce the submission of a NDA or new drug application to the FDA.

July 27, 2022

[mstock id=”73007″ asset=”cdtx”]

More than 700,000 in volume and 888 trades as of this post. The stock is bid at .79

https://www.globenewswire.com/news-release/2022/07/27/2486833/35407/en/Cidara-Therapeutics-Submits-NDA-for-Rezafungin-and-Announces-License-Agreement-with-Melinta-Therapeutics-for-Commercialization-of-Rezafungin-in-the-U-S.html

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.